Emergence of Macrolide Resistance in Throat Culture Isolates of Group A Streptococci in Ontario, Canada, in 2001-Reference-Cited by-同舟云学术

Emergence of Macrolide Resistance in Throat Culture Isolates of Group A Streptococci in Ontario, Canada, in 2001

Published:2003-07 Issue:7 Volume:47 Page:2370-2372
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Katz Kevin C.¹²,McGeer Allison J.¹²,Duncan Carla L.¹,Ashi-Sulaiman Aisha¹,Willey Barbara M.¹,Sarabia Alicia³,McCann Jacquie³,Pong-Porter Sylvia¹,Rzayev Yana¹,de Azavedo Joyce S.¹²,Low Donald E.¹²

Affiliation:

1. Toronto Medical Laboratories/Mount Sinai Hospital Department of Microbiology

2. University of Toronto

3. MDS Laboratories, Toronto, Ontario, Canada

Abstract

ABSTRACT Of 500 group A streptococci isolated from pharyngeal swabs, 72 (14.4%) were macrolide resistant, compared to 2.1% in 1997. Of these, 66 (92%) were of the M phenotype and 6 (8.3%) were of the MLS phenotype. Pulsed-field gel electrophoresis found that two clones, with patterns identical to those of serotypes M1 and M4, accounted for 19.4 and 68.1% of the macrolide-resistant isolates, respectively.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.47.7.2370-2372.2003

Reference23 articles.

1. Baquero, F. 1999. Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption? J. Chemother.11(Suppl. 1):35-43.

2. Bisno, A. L., M. A. Gerber, J. M. Gwaltney, Jr., E. L. Kaplan, and R. H. Schwartz. 2002. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin. Infect. Dis.35:113-125.

3. Critchley, I. A., D. F. Sahm, C. Thornsberry, R. S. Blosser-Middleton, M. E. Jones, and J. A. Karlowsky. 2002. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999. Diagn. Microbiol. Infect. Dis.42:129-135.

4. Prevalence and Mechanisms of Macrolide Resistance in Clinical Isolates of Group A Streptococci from Ontario, Canada

5. Demers, B., A. E. Simor, H. Vellend, P. M. Schlievert, S. Byrne, F. Jamieson, S. Walmsley, and D. E. Low. 1993. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis.16:792-800.

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Genomic Molecular Epidemiological Study of Macrolide-Resistant Streptococcus pyogenes in Iceland, 1995 to 2016: Identification of a Large Clonal Population with a pbp2x Mutation Conferring Reduced In Vitro β-Lactam Susceptibility;Journal of Clinical Microbiology;2020-08-24

2. Population genomic molecular epidemiological study of macrolide resistant Streptococcus pyogenes in Iceland, 1995-2016: Identification of a large clonal population with a pbp2x mutation conferring reduced in vitro β-lactam susceptibility;2020-05-13

3. Informing antimicrobial stewardship: factors associated with inappropriate antimicrobial prescribing in primary care;Family Practice;2017-12-10

4. Antibiotic Resistance of Non-pneumococcal Streptococci and Its Clinical Impact;Antimicrobial Drug Resistance;2017

5. Macrolide-resistantStreptococcus pyogenes: prevalence and treatment strategies;Expert Review of Anti-infective Therapy;2015-03-08